These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15960428)

  • 1. Structure-activity relationship studies of new acronine analogues as suggested by molecular descriptors.
    Neto MR; DaCosta JB; Sant'Anna CM; Carneiro JW
    Arzneimittelforschung; 2005; 55(5):282-8. PubMed ID: 15960428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series.
    Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F; Koch M; Pierré A; Atassi G
    J Nat Prod; 1998 Feb; 61(2):198-201. PubMed ID: 9514007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral dihydroxylation of acronycine: absolute configuration of natural cis-1,2-dihydroxy-1,2-dihydroacronycine and cytotoxicity of (1R,2R)- and (1S,2S)-1,2-diacetoxy-1,2-dihydroacronycine.
    Costes N; Michel S; Tillequin F; Koch M; Pierré A; Atassi G
    J Nat Prod; 1999 Mar; 62(3):490-2. PubMed ID: 10096866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cytotoxic activity of dimeric analogs of acronycine in the benzo[b]pyrano[3,2-h]acridin-7-one series.
    Gaslonde T; Michel S; Koch M; Pfeiffer B; Léonce S; Pierré A; Tillequin F
    Chem Pharm Bull (Tokyo); 2007 May; 55(5):734-8. PubMed ID: 17473459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives.
    Kolokythas G; Pouli N; Marakos P; Pratsinis H; Kletsas D
    Eur J Med Chem; 2006 Jan; 41(1):71-9. PubMed ID: 16300857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New antitumor agents in the acronycine series].
    Tillequin F
    Ann Pharm Fr; 2002 Jul; 60(4):246-52. PubMed ID: 12378151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships in the acronycine and benzo[b]acronycine series: role of the pyran ring.
    Do Q; Thi Mai HD; Gaslonde T; Pfeiffer B; Léonce S; Pierré A; Michel S; Tillequin F; Dufat H
    Eur J Med Chem; 2008 Dec; 43(12):2677-87. PubMed ID: 18342404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytotoxic activity of acronycine analogues in the benzo[c]pyrano[3,2-h]acridin-7-one and naphtho[1,2-b][1,7] and [1,10]-phenanthrolin-7(14H)-one series.
    Bongui JB; Elomri A; Cahard D; Tillequin F; Pfeiffer B; Pierré A; Seguin E
    Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1540-6. PubMed ID: 16327185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxic activity of benzophenanthrolinone analogues of acronycine.
    Bongui JB; Elomri A; Seguin E; Tillequin F; Pfeiffer B; Renard P; Pierré A; Atassi G
    Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1077-80. PubMed ID: 11558589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxic activity of benzo[a]acronycine and benzo[b]acronycine substituted on the A ring.
    Gaslonde T; Covello F; Velazquez-Alonso L; Léonce S; Pierré A; Pfeiffer B; Michel S; Tillequin F
    Eur J Med Chem; 2011 May; 46(5):1861-73. PubMed ID: 21411193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,2-dimethyl-2H-pyran-derived alkaloids I. Practical synthesis of acronycine and benzo[b]acronycine and their biological properties.
    Motiur Rahman AF; Liang JL; Lee SH; Son JK; Jung MJ; Kwon Y; Jahng Y
    Arch Pharm Res; 2008 Sep; 31(9):1087-93. PubMed ID: 18806949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
    Doan Thi Mai H; Gaslonde T; Michel S; Koch M; Tillequin F; Pfeiffer B; Renard P; Kraus-Berthier L; Léonce S; Pierré A
    Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):293-7. PubMed ID: 14993749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cytotoxic activity of 11-nitro and 11-amino derivatives of acronycine and 6-demethoxyacronycine.
    Elomri A; Michel S; Koch M; Seguin E; Tillequin F; Pierré A; Atassi G
    Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1604-6. PubMed ID: 10605058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of some new pyranoxanthenone aminoderivatives with cytotoxic activity.
    Kolokythas G; Kostakis IK; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1443-6. PubMed ID: 12031316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Oxo-2-hydroxy-1,2-dihydroacronycine: a useful synthon in the acronycine series for the introduction of amino substituents at 6-position and for the conversion into isopropylfuroacridones.
    Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1304-7. PubMed ID: 11605659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structure activity relationships and mechanism of action of antitumor benzo[b]acronycine antitumor agents].
    Seguin E; Tillequin F
    Ann Pharm Fr; 2005 Jan; 63(1):44-52. PubMed ID: 15803100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxic activity of pyranophenanthridine analogues of fagaronine and acronycine.
    Razafimbelo J; Baudouin G; Tillequin F; Renard P; Léonce S; Pierré A; Atassi G
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):34-41. PubMed ID: 9468635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cytotoxic activity of 1-alkoxy- and 1-amino-2-hydroxy-1,2-dihydroacronycine derivatives.
    Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F; Koch M; Pierré A; Atassi G
    Chem Pharm Bull (Tokyo); 1999 May; 47(5):611-4. PubMed ID: 10361696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, antitumor activity, and mechanism of action of benzo[a]pyrano[3,2-h]acridin-7-one analogues of acronycine.
    Nguyen TM; Sittisombut C; Boutefnouchet S; Lallemand MC; Michel S; Koch M; Tillequin F; Mazinghien R; Lansiaux A; David-Cordonnier MH; Pfeiffer B; Kraus-Berthier L; Léonce S; Pierré A
    J Med Chem; 2006 Jun; 49(11):3383-94. PubMed ID: 16722658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
    Koch M
    Bull Acad Natl Med; 2007 Jan; 191(1):83-91; discussion 91-3. PubMed ID: 17645109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.